
IPG Photonics (IPGP) Stock Forecast & Price Target
IPG Photonics (IPGP) Analyst Ratings
Bulls say
IPG Photonics is favorably viewed because it combines global leadership in fiber lasers with a broad, vertically integrated product portfolio that supports industry-leading margins and a resilient balance sheet, including $884MM of net cash/investments and a debt-free capital structure. Despite 2025 headwinds from legacy cutting weakness, competition, tariffs, and macro softness in Europe, the business is showing stronger underlying demand through a 54% Q4'25 sales contribution from emerging products, Q1'26 revenue of $265.5MM (+17% y/y) above guidance, and a second consecutive book-to-bill above 1.0, while management’s focus on battery manufacturing, semiconductor, and medical applications should diversify growth beyond cyclical industrial cutting. The positive outlook is further supported by the planned Lumibird Medical acquisition, which expands IPG’s Medical TAM to $2B and lifts Advanced Solutions to 26% of revenue, alongside expected margin improvement in 2026 and 2027 as cost initiatives, operating leverage, and tariff normalization help the company move toward its mid-40s structural gross margin target.
Bears say
IPG Photonics is facing a fundamentally challenged setup because its recent improvement is still coming off several quarters of deteriorating demand, with weakness in the legacy cutting business, increased competition, and macro-related softness in Europe offsetting progress elsewhere. Although Q1 revenue grew 17% year over year to $265.5 million and book-to-bill was firmly above 1.0, the quarter also showed that profitability remains pressured, as GAAP EPS fell to $0.04 from $0.09 and adjusted gross margin was 37.8%, down 220 bps year over year on tariffs and higher product costs. Even with strong North America, China, and Japan demand and the emerging products portfolio reaching 54% of sales in Q4’25, the company’s reliance on uneven industrial recovery, elevated operating expenses of $92 million to $95 million, and explicit 150 bps tariff headwinds in Q2’26 guidance support a cautious outlook.
This aggregate rating is based on analysts' research of IPG Photonics and is not a guaranteed prediction by Public.com or investment advice.
IPG Photonics (IPGP) Analyst Forecast & Price Prediction
Start investing in IPG Photonics (IPGP)
Order type
Buy in
Order amount
Est. shares
0 shares